跳至主要内容
临床试验/NCT03160976
NCT03160976Unknown不适用

Effects of Cryolipolysis on Localized Adiposity: Randomized Clinical Trial

Federal University of Health Science of Porto Alegre2 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2017年5月25日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
28
试验地点
2
主要终点
Subcutaneous fat layer

研究概览

简要总结

The aim of this study is to analyze the effects of a single session of cryolipolysis on localized adiposity on women's abdomen. This is a randomized controlled clinical trial that will include 28 women who will be randomly allocated into two groups: Control Group or Intervention Group. The following assessments will be performed in both groups: ultrasonography and body composition at baseline and 30, 60 and 90 days after randomization and blood analysis at baseline and 15 and 30 days after randomization. The expected main result at the end of this study is the reduction of the local subcutaneous fat tissue.

详细描述

Cryolipolysis is a non - invasive method for localized fat reduction wich uses low temperatures to induce an apoptotic and inflammatory response and consequent adipocyte death in the treated area. Although the practice of this technique has been increasing, there are some gaps in the literature about the exact mechanism of action and only a few randomized clinical trials that proves its effectiveness and safety. Then, the aim of this study is to analyse the effects of cryolipolysis on localized fat on women's abdomen. This is a randomized controlled clinical trial that will include 28 women who will be randomized to Control Group (CG) or Intervention Group (IG). The CG will perform the Evaluation Protocol with the following assessments: ultrasonography, thermographic analysis, blood analysis, bioimpedance and measurement of skinfold and abdominal circumference. The IG will receive a single cryolipolysis's session on lower abdomen and the Evaluation Protocol. The follow up for both groups is 90 days. Expected main result at the end of the study is the reduction of the local subcutaneous fat tissue.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 18 to 45 or not being on menopause
  • Sedentary according to International Physical Activity Questionnaire
  • Body Mass Index lower than 27 Kg/m²
  • Skinfold: more than 3 centimeters at the lower abdomen

排除标准

  • Cryoglobulinemia
  • Cold urticaria
  • Paroxysmal cold hemoglobinuria
  • Raynaud disease
  • Pregnancy and Breastfeeding
  • Vascular diseases
  • Heart diseases
  • Epidermal lesions at the site of application
  • Autoimmune diseases
  • Osteoporosis
  • Metallic implants and pacemaker
  • Alterations of sensibility
  • Inflammatory process and active infection
  • Abdominal hernia
  • Abdominal muscle diastasis
  • Previous plastic surgery on the area
  • Liver and kidney diseases
  • Cognitive impairment that prevents conducting evaluations, as well as inability to understand and sign the informed consent form

结局指标

主要结局

Subcutaneous fat layer

时间窗: Baseline, 30, 60 and 90 days after intervention.

Subcutaneous fat layer changes measured by ultrasonography and skinfold.

次要结局

  • Abdominal circumference(Baseline, 30, 60 and 90 days after intervention.)
  • Inflammatory profile(Baseline, 15 and 30 days after intervention.)
  • Body fat mass(Baseline, 30, 60 and 90 days after intervention.)
  • Kidney function(Baseline, 15 and 30 days after intervention.)
  • Local temperature(2 minutes before and 2 minutes after intervention and massage)
  • Physical Activity(Baseline and every 15 days after intervention)
  • Liver function(Baseline, 15 and 30 days after intervention.)
  • Lipids profile(Baseline, 15 and 30 days after intervention)
  • Adverse effects(15 days after intervention)
  • Pain level(First minute, twenty-fifth minute, fiftieth minute after intervention and first minute during the massage)
  • Body weight and body mass index(Baseline, 30, 60 and 90 days after intervention.)

研究者

发起方
Federal University of Health Science of Porto Alegre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rodrigo Della Méa Plentz

PhD

Federal University of Health Science of Porto Alegre

研究点 (2)

Loading locations...

相似试验